Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Context Partners Fund, L.P. (CIK 1505246) reported $460.1M across 153 reported positions in its SEC 13F filing for 2020-09-30. Largest positions: EGHT ($19.4M, 4.22%), ($13.1M, 2.84%), VNE ($12.8M, 2.77%), ICPT ($12.7M, 2.76%), AMAG ($12.6M, 2.74%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | EGHT | 8X8 INC NEW | $19.4M | 4.22% | 20.9M | New |
| 2 | SEA LTD | $13.1M | 2.84% | 7.0M | New | |
| 3 | VNE | VEONEER INCORPORATED | $12.8M | 2.77% | 12.9M | New |
| 4 | ICPT | INTERCEPT PHARMACEUTICALS IN | $12.7M | 2.76% | 15.8M | Added |
| 5 | AMAG | AMAG PHARMACEUTICALS INC | $12.6M | 2.74% | 14.1M | Added |
| 6 | CCIV.U | CHURCHILL CAPITAL CORP IV | $11.6M | 2.53% | 890,000 | New |
| 7 | CFIIU | CF FINANCE ACQUISITION CORP | $11.6M | 2.53% | 1.2M | New |
| 8 | NHIQ | NANTHEALTH INC | $11.3M | 2.46% | 12.2M | Added |
| 9 | INFN | INFINERA CORPORATION | $10.8M | 2.36% | 11.8M | Added |
| 10 | PRAA | PRA GROUP INC | $10.7M | 2.33% | 9.8M | New |
| 11 | FLXN | FLEXION THERAPEUTICS INC | $10.3M | 2.23% | 13.0M | New |
| 12 | NSH.U | NAVSIGHT HLDGS INC | $8.9M | 1.94% | 885,447 | New |
| 13 | CKH | SEACOR HOLDINGS INC | $8.8M | 1.91% | 9.9M | New |
| 14 | TVTX | RETROPHIN INC | $8.8M | 1.91% | 10.2M | New |
| 15 | IQ | IQIYI INC | $8.7M | 1.90% | 8.2M | New |
| 16 | OMER | OMEROS CORP | $8.5M | 1.85% | 9.0M | New |
| 17 | GOSS | GOSSAMER BIO INC | $7.4M | 1.61% | 7.2M | New |
| 18 | DISHR | DISH NETWORK CORP | $7.4M | 1.60% | 8.2M | New |
| 19 | VG2 | VONAGE HLDGS CORP | $7.0M | 1.52% | 7.3M | New |
| 20 | AGG | ISHARES TR | $6.4M | 1.40% | 54,600 | New |
| 21 | THERAVANCE BIOPHARMA INC | $6.3M | 1.38% | 7.2M | Added | |
| 22 | FIIIU | FORUM MERGER III CORP | $6.4M | 1.38% | 610,200 | New |
| 23 | XERS | XERIS PHARMACEUTICALS INC | $6.3M | 1.36% | 3.2M | New |
| 24 | BILI | BILIBILI INC | $6.2M | 1.34% | 3.5M | New |
| 25 | PSACU | PROPERTY SOLUTIONS ACQUISITI | $6.1M | 1.32% | 599,990 | New |
Source: SEC Form 13F filings · as of 2020-09-30